Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Moderna, Inc. (NASDAQ: MRNA)
MRNA Stock Predictions and Ratings
WSX Rating:
BUY
WSX Forecast (1yr):
13.20%
Analyst Rating:
HOLD
Analyst Forecast (1yr):
-27.50%
MRNA Stock Analysis
MRNA
PE Ratio:
MRNA
PEG Ratio:
Not Available
MRNA
Forward EPS Growth (12 month):
0.00%
MRNA
PS Ratio:
8.7
MRNA
PSG Ratio:
0.4
MRNA
Forward Revenue Growth (12 month):
20.80%
MRNA Articles
No data was found